Menu

Actinium Pharmaceuticals, Inc. ATNM

Full chart Compare
Set alert

Price alert · ATNM

All alert types
1.54 USD +0.11 (+7.69%)

At closeNov 9, 2026, 6:48 PM EST

1.57 +0.03 +1.95%

After hours · Nov 9, 6:48 PM ET

1.43 Day range 1.62
0.735 52-week range 1.72
YTD
+13.24%
1 year
+22.22%

Revenue & Expenses

Other Income → Expenses: $2.36MExpenses → Selling, General & Admin: $15.21MExpenses → Research & Development: $21.12MGross Profit → Expenses: $90.00KRevenue → Gross Profit: $90.00KNet Loss → Expenses: $33.89MOther Income$2.36MGross Profit$90.00KNet Loss$33.89MExpenses$36.34MSelling, General & Admin$15.21MResearch & Development$21.12MRevenue$90.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

ATNM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
90.00K081.00K1.03M1.14M
90.00K081.00K1.03M1.14M
90.00K081.00K1.03M1.14M
36.34M42.12M52.00M35.13M26.11M
21.12M30.05M38.67M23.14M18.03M
15.21M12.08M13.33M12.00M8.08M
-36.25M-42.12M-51.92M-34.10M-24.96M
-33.89M-38.24M-48.82M-33.02M-24.77M
-33.89M-38.24M-48.82M-33.02M-24.77M
-33.89M-38.24M-48.82M-33.02M-24.77M
-33.89M-38.24M-48.82M-33.02M-24.77M
-1.09-1.27-1.83-1.37-1.20
-1.09-1.27-1.83-1.37-1.20
-1.09-1.27-1.83-1.37-1.20
-33.89M-38.24M-48.82M-33.02M-24.77M
-33.89M-38.24M-48.82M-33.02M-24.77M
31.20M30.07M26.60M24.14M20.57M
31.20M30.07M26.60M24.14M20.57M